Skip to Content
Merck
  • Potentiometric flow injection sensing system for determination of heparin based on current-controlled release of protamine.

Potentiometric flow injection sensing system for determination of heparin based on current-controlled release of protamine.

Analytica chimica acta (2015-01-20)
Jiahong Lei, Jiawang Ding, Yan Chen, Wei Qin
ABSTRACT

A flow injection system incorporated with a polycation-sensitive polymeric membrane electrode in the flow cell is proposed for potentiometric determination of heparin. An external current in nano-ampere scale is continuously applied across the polymeric membrane for controlled release of protamine from the inner filling solution to the sample solution, which makes the electrode membrane regenerate quickly after each measurement. The protamine released at membrane-sample interface is consumed by heparin injected into the flow cell via their strong electrostatic interaction, thus decreasing the measured potential, by which heparin can be detected. Under optimized conditions, a linear relationship between the potential peak height and the concentration of heparin in the sample solution can be obtained in the range of 0.1-2.0 U mL(-1), and the detection limit is 0.06 U mL(-1). The proposed potentiometric sensing system has been successfully applied to the determination of heparin in undiluted sheep whole blood.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Heptane, biotech. grade, ≥99%
Supelco
Heptane, analytical standard
Sigma-Aldrich
Heptane, anhydrous, 99%
Supelco
Heptane, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Heptane, ReagentPlus®, 99%
Sigma-Aldrich
Heptane, HPLC Plus, for HPLC, GC, and residue analysis, 99%
Sigma-Aldrich
Heptane, suitable for HPLC, ≥99%
Sigma-Aldrich
Heptane, suitable for HPLC, ≥96%
Supelco
2-Nitrophenyl octyl ether, Selectophore, ≥99.0%
Sigma-Aldrich
2-Nitrophenyl octyl ether, 99%